Skip Navigation Links
AOAAM.org
Leadership
Committees
FAQ
Member Search
Mission Statement
Donate
Contact Us
Education
Review Course
Review Course Home
Register
Resources
FAQs
Faculty
Live Q&A Sessions
DEA 8-hour Course
Annual Convention OMED
AOA Addiction Medicine Subspecialty Certification
FAQs
Buprenorphine
The 8-hour Buprenorphine Training
NP-PA and Advanced Buprenorphine Trainings
PCSS Mentoring
PCSS News
Clinical Tools
Membership
Join Us - Renew
Events
FAQ
Forums
Member Search
AOAAM Fellow
Members Only
Board Members Only
Resources
General News
Position Papers
Journal of Addictive Diseases
Carrying and Administering of Intranasal Naloxone
Marijuana Pocket Card
Opioid Response Network (ORN)
Useful Links
Students
Career Center
Contact Us
Menu
AOAAM.org
Leadership
Committees
FAQ
Member Search
Mission Statement
Donate
Contact Us
Education
Review Course
DEA 8-hour Course
Annual Convention OMED
AOA Addiction Medicine Subspecialty Certification
FAQs
Buprenorphine
The 8-hour Buprenorphine Training
NP-PA and Advanced Buprenorphine Trainings
PCSS Mentoring
PCSS News
Clinical Tools
Membership
Join Us - Renew
Events
FAQ
Forums
Member Search
AOAAM Fellow
Members Only
Board Members Only
Resources
General News
Position Papers
Journal of Addictive Diseases
Carrying and Administering of Intranasal Naloxone
Marijuana Pocket Card
Opioid Response Network (ORN)
Useful Links
Students
Career Center
Contact Us
Hamburger Menu
Catalog
Calendar
Help & FAQ
Catalog
Why Preventing Drug Overdose Deaths is a Moving Ta ...
Why Preventing Drug Overdose Deaths is a Moving Target: Dynamic Shifts to the Opioid Crisis by Age, Race, Supply, Demand, and Geography
AVAILABLE ON-DEMAND
Available on-demand. Login or create an account to register to view the recording.
Description:
While Medicaid is a key policy lever to improve access to substance use disorder treatment, many state Medicaid The opioid crisis is a dynamic complex problem. Every time we make gains on the crisis, it shifts into a new wave of substances, moves geographically to new areas and impacts populations by age, race, and urban/rural status differentially. This lecture will provide an update as to novel forms of drugs, ingestion modes, drug supply and who is affected.
Learning Objectives:
At the end of the seminar learners will be able to:
To understand who is at risk for drug overdose deaths based on recent opioid surveillance.
To understand who is at risk for drug overdose deaths.
To discern which risk factors, such as incarceration or rehab, that place patients at an elevated risk for a drug overdose death.
Claim Credits & Course Materials
How to claim your credits & download handouts for each webinar:
Under the "Course" tab (or "Content" tab):
Complete the required course materials.
Claim your credits by clicking the "Report Credit" or "Request Credit" button on the right above the course materials.
Speakers:
Lori Ann Post, PhD
is the Buehler Professor for Aging in the Departments of Emergency Medicine and Medical Social Sciences at the Feinberg School of Medicine. She is the inaugural Director of the Buehler Center for Health Policy & Economics. Dr. Post is an injury control scientist whose work is focused on policy and injury prevention. As a Demographer and Epidemiologist, Dr. Post is expert in surveillance systems and policy to action research. She works on topics such as opioid overdose deaths, mass shootings, and other violence prevention projects.
Disclosure:
Funding for this initiative was made possible (in part) by grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Financial Disclosure & Disclaimer: This program receives no commercial financial support.
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by the AOA. In no event will the AOA be liable for any decision made or action taken in reliance upon the information provided through this CME.
Summary
Availability:
No future session
Expires on Dec 31, 2024
Cost:
FREE
Credit Offered:
1 AMA PRA Category 1 Credit
1 AOA Category 1A Credit
×
Why Preventing Drug Overdose Deaths is a Moving Target: Dynamic Shifts to the Opioid Crisis by Age, Race, Supply, Demand, and Geography Course List
Create Account
Recommended
Learning Activity Title
Learning Activity Title
Learning Activity Title
Isn't There a Better Way? Mitigating the Harms of Criminal Legal Involvement for Pregnant People Who Use Drugs
Multiple Credits
FREE
Enduring Activity
Online
(10)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Reducing Health Harms for People who Inject Drugs in Appalachia - Research and Practice Partnerships in Syringe Service Programs
Multiple Credits
FREE
Enduring Activity
Online
(5)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Medicaid Managed Care Coverage for Substance Use Disorder Treatment
Multiple Credits
FREE
Enduring Activity
Online
(5)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Innovation and Regulation: Improving Methadone Access While Maintaining Treatment Quality and Safety
Multiple Credits
FREE
Enduring Activity
Online
(2)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Update on the U.S. Overdose Crisis: Which drugs, who is dying, and how do we save lives?
Multiple Credits
FREE
Enduring Activity
Online
(3)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Xylazine - An Introduction to a New Drug
Multiple Credits
FREE
Enduring Activity
Online
(7)
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Evolution of Buprenorphine: Prescribing practices and efforts to increase MOUD access
Multiple Credits
FREE
Enduring Activity
Online
(2)
Learning Activity Title
Learning Activity Title
Learning Activity Title
New Approaches to Methamphetamine Addiction and Psychosis
Multiple Credits
FREE
Enduring Activity
Online
(6)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Brixadi (buprenorphine-XR) for the Treatment of Opioid Use Disorder
1 AOA Category 1A
FREE
Enduring Activity
Online
(2)
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English